Lavandin

Synopsis

Lavandin (Lavandula × intermedia): A Comprehensive Reference

1. Identity, Taxonomy, and Nomenclature

Lavandin — formally designated Lavandula × intermedia Emeric ex Loisel — is also known as Dutch lavender or bastard lavender, and is a widely cultivated aromatic plant belonging to the family Lamiaceae. It is a hybrid of true lavender (Lavandula angustifolia) and spike lavender (Lavandula latifolia). The multiplication sign (×) in the binomial name formally denotes its hybrid status. Synonyms encountered in trade literature include Lavandula hybrida Reverchon and Lavandula hybrida Balb., though Lavandula × intermedia Emeric ex Loisel is the accepted scientific name. The common name "lavandin" originates in French and is now used internationally across perfumery, cosmetics, and botanical commerce.

Spike lavender grows at lower altitudes, while true lavender grows at higher altitudes. There is an altitude band — approximately between 1,500 and 2,100 feet — where both parent species can grow simultaneously. Cross-pollination in that overlap zone may occur, and lavandin is the natural result. It is a sterile hybrid. It cannot be reproduced by seed and must be propagated only by cuttings, which makes its planting relatively straightforward. It is sturdier than true lavender, and its yield in oil is significantly higher.

Despite its prevalence in cultivation and on the essential oil market, lavandin has received limited attention from the scientific community. Remarkably more attention is paid to Lavandula angustifolia, which is commonly regarded as the superior lavender and has been extensively researched. Most of the lavender essential oil in commercial use is, in fact, lavandin essential oil. Additionally, true lavender essential oil is commonly adulterated — usually by dilution with lavandin essential oil.

1.1 Morphology and Distinguishing Features

Both leaf size and plant height — approximately 3 feet — are larger in lavandin when compared to English lavender. Typically, lavandin varieties bloom 3–4 weeks later than English lavender and have significantly higher essential oil concentrations. Lavandin is one of the main taxa cultivated for producing essential oil and for its horticultural importance. Many cultivars of lavandin are created in connection with different requirements; for example, 'Alba' was developed for white flowers, 'Grosso' for its tolerance to disease dieback, and 'Hidcote Giant' for the strongest scent.

1.2 Principal Cultivars

Commercially, L. × intermedia is grown to produce essential oils and for its horticultural importance; the most common cultivars are 'Super', 'Grosso', and 'Abrial'. France, Spain, and Morocco are the leading producers of lavandin essential oils.

Grosso: This clone was developed by M. Grosso from Gault, Vaucluse. It is robust and productive and became very popular from 1972–1975 onwards. 'Grosso' represents approximately three-quarters of the cultivated production areas, and in certain regions — such as the Plateau de Valensole — more than 90 percent. Lavandin Grosso is now the most commercially produced cultivar due to its resistance to disease compared to Abrialis and Super varieties. Lavandin production, especially Lavandin Grosso, is highly cost-effective due to its higher essential oil yield.
Abrialis: In the 1920s, interest in producing new types of lavandin grew in Grasse, but it was Père Abrial in the 1930s who produced the first lavandin of great commercial interest. The lavandin carried his name as 'Abrialis', and it became so popular that two-thirds of all fields were planted with this variety. It subsequently developed an illness described in French as dépérissement (a plant fatigue) and was replaced by a new variety, 'Super'.
Super: Chemically, Lavandin Super and Lavandin Abrialis are closest to the original Lavandula vera. The Super cultivar succeeded Abrialis but eventually also fell victim to the same soil-associated fatigue attributed to lack of crop rotation.

1.3 Dosage Forms and Commercial Preparations

Lavandin is available commercially in several forms, all derived from the aerial flowering portions of the plant:

Essential oil (steam-distilled): The primary commercial form. To extract 1 lb (0.45 kg) of lavandin oil, only approximately 80 lbs (36 kg) of lavandin plant material is needed — compared with true lavender, which requires up to 150 lbs (68 kg) to yield 1 lb (0.45 kg) of essential oil. The oil ranges in color from colorless to pale yellow.
Hydrolate (floral water): The aqueous by-product of steam distillation, containing water-soluble volatile compounds. This preparation has been investigated in research contexts, particularly for nematicidal applications.
Dried flowers and flowering tops: Used in sachets, potpourri, and traditional herbal preparations.
Absolute: A solvent-extracted concentrate used in high-end perfumery, more concentrated than the essential oil.

2. Historical and Traditional Use

The first uses of lavender recorded in ancient cultures were medicinal in nature. Dioscorides, an ancient Greek physician, believed that eating lavender would relieve indigestion, sore throats, and headaches. The Romans, who colonized Provence in the 2nd century BC, were among the first to recognize the value of lavender, using it for its medicinal properties, as a perfume, and for its soothing qualities in baths. The name "lavender" itself is derived from the Latin word lavare, meaning "to wash," reflecting its widespread use in cleansing and bathing rituals.

It is important to note that the botanical entity historically cultivated in the Mediterranean and referenced in ancient and medieval texts was predominantly Lavandula angustifolia (true lavender), not lavandin specifically. Farmers became very interested in the lavandin hybrid after the First World War, when they took cuttings from the healthiest plants found in nature and started cultivation on a large scale. Lavandin as a distinct, commercially managed crop is therefore largely a 20th-century phenomenon, even though the natural hybrid may have arisen spontaneously in the wild for centuries.

By the early 20th century, Provence was producing lavender oil on a commercial scale sufficient to supply the global perfume and soap industries. The introduction of lavandin hybrids in the mid-20th century — which produce three to five times more oil per hectare than true lavender — revolutionized the economics of the industry but created the quality stratification that exists today.

Throughout the Middle Ages, lavender continued to be cultivated in Provence, where it was used in monasteries and by herbalists for its healing properties. Monastic herb gardens across southern France and the Iberian Peninsula incorporated lavender species — of which lavandin is the modern commercial successor — for their reputed antiseptic, calming, and aromatic properties. However, it was not until the 19th century that lavender farming became a significant part of the regional agricultural economy. The development of the perfume industry in nearby Grasse, often referred to as the "perfume capital of the world," created a growing demand for lavender essential oil.

In traditional folk herbalism, preparations of lavender and, by extension, lavandin have historically been applied topically to minor wounds, burns, and skin irritations; inhaled for respiratory complaints; and consumed as herbal teas or infusions for nervous tension and digestive discomfort. These traditions predate formal distinction between L. angustifolia and the lavandin hybrid.

3. Key Constituents and Active Compounds

Lavandin essential oil is characterized by a high content of polar terpenoids, especially oxygenated monoterpenes. The most characteristic compounds in these oils are 1,8-cineole, linalool, camphor, borneol, terpinen-4-ol, linalyl acetate, lavandulol, and lavandulyl acetate. Other compounds such as monoterpene and sesquiterpene hydrocarbons are also present — including α- and β-pinene, myrcene, sabinene, 3-carene, α-terpinene, α-santalene, germacrene D, (E)-β-caryophyllene, and trans-α-bergamotene — but the levels of these compounds are much lower than those of the polar constituents.

3.1 Major Constituents and Characteristic Concentration Ranges

The most abundant components of lavandin essential oils are linalool and linalyl acetate, which can occur from a few percent to exceeding 50%, but usually over 20%. Other dominant terpenoids include camphor (ranging from 2–33%, but most frequently occurring at levels from 5–10%), borneol (1–26%, typically a few percent), and 1,8-cineole (2–49%, usually a few percent). Additionally, significant volatile compounds include terpinen-4-ol (0.4–16%) and α-terpineol (2–10%), which typically contribute up to 5% of the essential oil.

For reference, the ISO standard 8902:2009 specifies the following ranges for lavandin oil quality: lavandin essential oil contains linalyl acetate (28–38%), linalool (24–35%), and camphor (6–8%) according to ISO 8902:2009.

Lavandin essential oil also contains characteristic terpenoids lavandulol and its ester, lavandulyl acetate, present at levels ranging from a fraction of a percent to 3%.

3.2 Key Compositional Differences from True Lavender

The chemical composition of lavandin and true lavender essential oils is similar but not identical. Lavandin essential oil contains mainly linalool and linalyl acetate, the same as true lavender oil. Other components are mostly oxygenated monoterpenes and are also comparable with L. angustifolia, except for 1,8-cineole, camphor, and borneol, which are more abundant in the lavandin essential oil. The chemical composition of lavandin oil is similar to that of L. angustifolia but contains more terpenes, giving camphor notes that are less valued in perfumery.

3.3 Cultivar-Dependent Variation

Major components of lavandin essential oil vary considerably by plant part: linalool (24.97–43.86%), linalyl acetate (3.4–15.76%), eucalyptol (12.08–43.81%), camphor (8.72–15.91%), endo-borneol (0.68–5.18%), and alpha-terpineol (1.28–3.86%) across stem, leaf, flower, and mixed fractions. The content, composition, and consequently the biological activities of lavandin essential oil are highly dependent on the plant cultivar, as well as being largely affected by agronomical and technical factors such as harvest time, drying temperature, and distillation time.

4. Mechanisms of Action

4.1 Central Nervous System: Anxiolytic and Sedative Mechanisms

The combination of main constituents in lavender-type oils, especially linalool and its acetate, produces an anxiolytic and sedative action depending on the inhibition of voltage-dependent calcium channels, reduces the activity of 5-HT1A receptors, and stimulates the parasympathetic system. Due to its volatilization, receptor cells of the nasal cavity capture biological signals, followed by their transmission to the limbic system and hypothalamus and the release of neurotransmitters, which act on the parasympathetic system and promote relaxation.

Research on linalool — the primary constituent shared between lavandin and true lavender — has further elucidated mechanisms in preclinical models. Studies in mice using light/dark box and elevated plus maze (EPM) tests demonstrated that linalool odor has an anxiolytic effect without motor impairment. The effect was not observed in anosmic mice, indicating it was triggered by olfactory input evoked by linalool odor. Furthermore, the effect was antagonized by flumazenil, indicating that the linalool odor-induced anxiolytic effect was mediated by GABAergic transmission via benzodiazepine-responsive GABA_A receptors.

4.2 Anti-inflammatory Mechanisms

Scientists have found that linalool reduced the production of TNF-α and IL-6 both in stimulated macrophages in vitro and in vivo in lung injury mouse models, and that linalool treatment attenuated lung histopathology in mice. In search of molecular mechanisms, researchers investigated the phosphorylation of proteins in the NF-κB and MAPK pathways. Nuclear factor-κB (NF-κB) is the critical dimer protein controlling the expression of over 500 genes, including many inflammation-associated factors. These findings are derived from preclinical models; whether they translate directly to human therapeutic contexts at doses achievable through normal use of lavandin essential oil has not been fully established.

4.3 Antimicrobial Mechanisms

The antimicrobial activity of lavandin essential oil is attributed principally to its high content of oxygenated monoterpenes. Linalool and 1,8-cineole are believed to disrupt bacterial and fungal cell membrane integrity, impair enzyme function, and alter membrane permeability. These mechanisms are consistent with the established mode of action of terpene-rich essential oils generally and are supported by the in vitro minimum inhibitory concentration (MIC) data reported across multiple studies (see Section 5.2 below).

5. Scientific Evidence by Area of Use

Critical note on evidence base: For therapeutic purposes, lavandin is used in aromatherapy sessions, although, except for WHO, lavandin oil is not officially recognized as a medical agent. The research is either limited or inconsistent across all studies, and further evidence is needed to support reported properties. Unlike its parent species — Lavandula angustifolia — lavandin essential oil is not officially recognized as a medicinal raw material in the European Pharmacopoeia. The vast majority of biological activity research on lavandin specifically employs in vitro models or animal studies; robust human clinical trials dedicated to lavandin (as distinct from L. angustifolia) are sparse.

5.1 Anxiolytic and Sedative Effects

Lavandin essential oil has been found to have potential therapeutic effects including anxiolytic, neuroprotective, and sleep quality-improving properties, among others. However, most of the human clinical evidence for lavender-type oils as anxiolytics comes from studies using Lavandula angustifolia, not lavandin specifically. Evidence for lavender-related essential oils in wound healing, pain relief, and antimicrobial effects is weaker. L. angustifolia is the species used in most clinical research, making it difficult to extrapolate effect sizes directly to lavandin preparations.

Mechanistic preclinical data reviewed in the context of lavandin's constituent linalool suggests GABAergic modulation as a plausible pathway (see Section 4.1), but human randomized controlled trials specifically testing lavandin for anxiety or sleep have not been robustly reported in the peer-reviewed literature as of the most current comprehensive review (Pokajewicz et al., 2023). The research is either limited or inconsistent across all studies, and further evidence is needed to support these properties.

5.2 Antimicrobial Activity

Antimicrobial studies of lavandin oil are usually conducted in vitro using agar diffusion methods (disc or well) and/or dilution methods. The diffusion methods are mainly used for antimicrobial susceptibility testing, while dilution methods are the most suitable for determining minimum inhibitory concentration (MIC), minimum lethal concentration (MLC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC) values.

The antibacterial and antifungal effect of lavandin essential oils against many gram-positive and gram-negative bacteria has been demonstrated by multiple researchers. In most cases, L. × intermedia antibacterial activity was higher than that of true lavender. Stronger action of lavandin was also observed by Tardugno and co-workers, who tested essential oils of different cultivars of lavandin and L. angustifolia (Italian origin) against Listeria monocytogenes.

Robu and colleagues tested Romanian lavandin and true lavender essential oils against S. aureus, S. pyogenes, P. aeruginosa, E. coli, and Candida albicans, and noticed that L. angustifolia essential oil was more active on certain bacterial strains, but L. × intermedia essential oil was more effective against Candida. Antifungal properties of lavandin essential oil in high doses against Candida albicans were also noted by Karakaş and Bekler.

For the Grosso cultivar grown in Lazio, Italy, the most abundant components were found to be linalool and linalyl acetate, followed by 1,8-cineole and terpinen-4-ol, while lavandulyl acetate and borneol were identified as minor compounds. The same study tested lavandin liquid and vapor-phase essential oil on gram-negative bacteria (Escherichia coli, Acinetobacter bohemicus, and Pseudomonas fluorescens) and gram-positive bacteria (Bacillus cereus and Kocuria marina).

Evidence strength: Antimicrobial evidence is predominantly in vitro. No high-quality randomized human trials have evaluated lavandin essential oil as a standalone antimicrobial agent in clinical infection scenarios. Results vary substantially across cultivars and studies, limiting generalizability.

5.3 Antioxidant Activity

Lavandin essential oil has been found to have antioxidant and biocidal activity. In vitro antioxidant testing of lavandin essential oil has been conducted using standard assays such as DPPH radical scavenging. Results show measurable antioxidant capacity, attributable primarily to linalool, linalyl acetate, and minor phenolic components. As with antimicrobial studies, these findings are in vitro only, and their relevance to human antioxidant status following aromatherapeutic or topical use has not been established in clinical trials.

5.4 Anti-inflammatory Activity

Anti-inflammatory effects of lavandin essential oil have been studied in preclinical models. Scientists have found that linalool reduced the production of TNF-α and IL-6 both in stimulated macrophages in vitro and in vivo in lung injury mouse models, and that linalool treatment attenuated lung histopathology in mice. Additional preclinical work on topical application of lavender-type oils has demonstrated reduction in ear edema, myeloperoxidase activity, and nitric oxide production in rodent models of acute inflammation. Evidence directly from human clinical trials on lavandin specifically is absent from the peer-reviewed literature as of the 2023 comprehensive review by Pokajewicz et al.

5.5 Insecticidal and Nematicidal Activity

This is an area where lavandin-specific research is relatively more developed. Essential oils from lavandin are known for a broad spectrum of biological properties but are poorly and contrastingly documented for their activity against phytoparasitic nematodes. One study investigated the toxicity of essential oils from three different lavandin cultivars — Abrialis, Rinaldi Cerioni, and Sumiens — either to juveniles (J2) and eggs of the root-knot nematode Meloidogyne incognita and to infective stages of the lesion nematode Pratylenchus vulnus.

The mortality of M. incognita J2 peaked at 82.0%, 95.8%, and 89.8% after a 24-hour treatment with 100 mg/mL solutions of cv. Abrialis, Rinaldi Cerioni, and Sumiens essential oils, respectively. Infective specimens of P. vulnus were markedly more sensitive than M. incognita J2, with peak mortality rates of 65.5%, 67.7%, and 75.7% after 4 hours of exposure to the three cultivars' essential oils, respectively. All three lavandin essential oils significantly affected M. incognita egg hatchability, which reduced to 43.6% after a 48-hour egg mass exposure to a 100 µg/mL solution of cv. Rinaldi Cerioni essential oil.

Lavandin essential oil can be a promising raw material for the formulation of crop pesticides, as proved for insecticidal activity against crop parasites such as Drosophila suzukii Matsumura and Spodoptera littoralis Boisduval, or the stored-product parasites Acanthoscelides obtectus Say and Sitophilus zeamais Motschulsky. Additionally, essential oils or extraction waste materials from lavandin were also reported for contact, repellency, and ovicidal effects on Tetranychus urticae Koch, as well as for their toxicity to fungal crop pathogens such as Alternaria alternata and Verticillium dahliae.

5.6 Antithrombotic Activity

Antithrombotic activity is among the potential therapeutic effects reported for lavandin essential oil in the research literature. Original research by Ballabeni and colleagues (2004, Journal of Cardiovascular Pharmacology) on Lavandula hybrida Reverchon essential oil reported antiplatelet and antithrombotic activities in in vitro and ex vivo models. These findings are preliminary and no human clinical trials on the antithrombotic potential of lavandin have been identified.

5.7 Analgesic Activity

Analgesic properties are among the potential therapeutic effects identified for lavandin essential oil. Preclinical rodent studies using standard pain models (writhing test, hot plate test) have shown nociceptive-reducing effects of lavender-type essential oils and their constituent linalool. Human clinical evidence for lavandin specifically as an analgesic remains limited; most clinical data on lavender-type oils for pain management come from studies of L. angustifolia.

5.8 Antiprotozoal Activity

Antiprotozoal activity has been reported as part of the biocidal profile of lavandin essential oil. In vitro studies have explored activity against organisms such as Leishmania and Trypanosoma species, with results indicating dose-dependent inhibitory effects. This area of research is at an early stage and no clinical data in human parasitic infections exist for lavandin.

6. Body Systems and Health Areas of Association

Based on the available peer-reviewed literature, lavandin essential oil has been investigated in relation to the following body systems and health domains:

Central and peripheral nervous system: Anxiolytic effects (via GABAergic and calcium-channel modulation), sedation, sleep quality improvement, and neuroprotection — primarily in preclinical models, with some translational extrapolation from L. angustifolia human studies.
Immune system / inflammatory pathways: Modulation of pro-inflammatory cytokines (TNF-α, IL-6) and NF-κB signaling in preclinical models; anti-inflammatory and antioxidant activity in vitro.
Integumentary system (skin): Topical antiseptic, antibacterial, and antifungal applications in traditional and contemporary practice; preliminary wound-healing associations; established sensitization risk with oxidized constituents (see Safety section).
Cardiovascular system: Preliminary antiplatelet and antithrombotic findings in in vitro / ex vivo models.
Musculoskeletal system: Analgesic effects in preclinical models; used traditionally for muscle and joint discomfort via topical or aromatic application.
Respiratory system: 1,8-cineole content supports traditional use as an expectorant and mucolytic, consistent with the documented properties of this constituent in other botanical contexts.

7. Dosage Forms and Dosages Reported in Studies

Lavandin is not currently classified as a pharmaceutical drug in most jurisdictions, and standardized therapeutic dosage protocols based on robust human clinical trials specific to lavandin do not exist. The following dosage information reflects what is reported in the scientific literature and applied in research settings:

Aromatherapy inhalation: Typically administered via diffuser or direct inhalation. Study protocols for lavender-type oils in anxiety research commonly employ undiluted oil in diffuser devices for periods of 15–60 minutes per session, though specific lavandin concentrations are rarely standardized.
Topical application: In research and clinical use, lavender-type essential oils — including lavandin — are invariably diluted in a carrier oil before dermal application. Common research dilutions range from 1% to 3% v/v essential oil in carrier, consistent with general essential oil safety guidance. Undiluted application to skin is considered unsafe (see Section 8).
In vitro antimicrobial studies: Nematicidal bioassays used 100 mg/mL solutions of lavandin essential oil, with mortality of M. incognita J2 peaking at 82.0%, 95.8%, and 89.8% after a 24-hour treatment with cv. Abrialis, Rinaldi Cerioni, and Sumiens essential oils, respectively.
Oral administration (animal studies): In lavender essential oil acute toxicity testing in mice, a limit test at 2000 mg/kg dose was used, revealing an LD₅₀ value higher than 2000 mg/kg. In a subacute toxicity study, 2000 mg/kg was given orally to each mouse for 21 days; results demonstrated no significant changes in body weights, biochemical parameters, gross abnormalities, water intake, or food intake. Note: these studies are on L. angustifolia oil, not lavandin specifically, and are in mice; direct extrapolation to human oral doses is not appropriate.

8. Safety, Tolerability, and Known Interactions

8.1 Contact Sensitization from Oxidized Constituents

The most significant and well-documented safety concern for lavandin essential oil — shared with all linalool- and linalyl acetate-rich essential oils — is the formation of potent contact allergens upon air oxidation of its major constituents. Analyses showed that the content of linalyl acetate decreases over time on air exposure and other compounds form. Hydroperoxides, an epoxide, and an alcohol were identified as oxidation products from linalyl acetate. In the Local Lymph Node Assay (LLNA), linalyl acetate of high purity showed only a weak sensitizing potency (EC3 25%). However, autoxidation markedly increased sensitizing potency, with a 10-week oxidized sample giving an EC3 value of 3.6%. Lavender oil lacks natural protection against autoxidation, forming strong contact allergens on air exposure.

Linalool autoxidizes on air exposure, and the oxidation products can cause contact allergy. In a Swedish study, oxidized linalool 6.0% in petrolatum gave 5% positive patch test reactions in 2,500 dermatitis patients. A larger retrospective study extended this finding: a retrospective analysis of 5,773 patients who were patch tested from 2013 to 2020 found that the prevalence rates of contact allergy to oxidized linalool and oxidized limonene were 7.0% and 5.1%, respectively, with significantly increasing trends of contact allergy observed over time.

8.2 Camphor Content and Associated Risks

Lavandin essential oil contains substantially higher levels of camphor than true lavender oil — typically 6–10% by ISO specification, with some cultivars reaching higher levels. Camphor is a known neurotoxic compound at elevated doses; ingestion of even small amounts of undiluted camphor-containing essential oils can cause convulsions, particularly in young children. While topical or aromatic use at appropriate dilutions does not present the same risk, the elevated camphor content of lavandin versus true lavender is a clinically relevant distinguishing feature. Lavandin essential oil is therefore considered less appropriate than L. angustifolia oil for use around infants and young children.

8.3 Skin Application

Lavandin essential oil should always be diluted before application to the skin. Although some aromatherapy publications may claim that lavandin essential oil can be used undiluted on the skin, this is a very unsafe practice and is strongly discouraged. There are individuals who have developed severe sensitization and other complications from using it undiluted.

8.4 Regulatory and Industry Standards

The International Fragrance Association (IFRA) develops voluntary global standards for fragrance safety. The latest 51st Amendment details restrictions and prohibitions for over 200 materials. Lavandin absolute and essential oil are covered by IFRA guidelines that set maximum permitted concentrations in consumer products by category. The EU Cosmetics Regulation (EC 1223/2009) requires labeling of linalool and linalyl acetate when their concentrations in finished products exceed 0.001% (rinse-off) and 0.01% (leave-on), due to their recognized sensitization potential as oxidized derivatives.

8.5 Adulteration and Misidentification

True lavender essential oil is commonly adulterated — usually by its dilution with lavandin essential oil. The chemical composition of both oils is similar but not identical. Consumers and practitioners should therefore be aware that products labeled as "lavender essential oil" may contain varying proportions of lavandin, particularly in lower-cost products. Gas chromatography–mass spectrometry (GC-MS) analysis is the standard analytical method for authentication. This distinction is clinically relevant because camphor content — substantially higher in lavandin — is one of the principal markers used to distinguish the two oils.

8.6 Potential Drug Interactions

Preclinical evidence indicates that linalool — the primary constituent of lavandin oil — modulates GABA_A receptors and voltage-dependent calcium channels. Theoretically, concurrent use of lavandin aromatherapy with CNS depressants (sedatives, benzodiazepines, anesthetics) could produce additive sedative effects, though this has not been confirmed in human pharmacokinetic interaction studies. The high camphor content also theoretically warrants caution in individuals taking medications with narrow therapeutic indices metabolized by cytochrome P450 enzymes, as camphor is known to interact with CYP enzyme systems, though specific interaction data for lavandin are lacking in the human literature.

9. Regulatory Status

For therapeutic purposes, lavandin is used in aromatherapy sessions, although, except for WHO, lavandin oil is not recognized officially as any medical agent. Lavandula angustifolia essential oil, acknowledged by the European Pharmacopoeia, receives the most attention from the scientific community. Lavandin is widely used as a fragrance ingredient and is listed in the Cosmetics Ingredient Database (CosIng) of the European Commission. It is also generally recognized in the context of the U.S. FEMA (Flavor and Extract Manufacturers Association) GRAS (Generally Recognized As Safe) list in the context of food flavoring, though it is used far more extensively in fragrance and personal care applications than in food.

10. Summary of Evidence Quality

The table below summarizes the strength of evidence for lavandin's major reported activities, based on the types of studies available:

Antimicrobial (in vitro): Multiple consistent in vitro studies; no human RCTs specific to lavandin. Evidence level: Preliminary (in vitro only).
Antifungal (in vitro): In vitro studies show activity, particularly against Candida. Evidence level: Preliminary (in vitro only).
Anxiolytic / sedative: Mechanistic preclinical data; human clinical trials exist for L. angustifolia but not specifically for lavandin. Evidence level: Weak direct evidence; extrapolation from related species.
Anti-inflammatory: Preclinical (cell and animal) data; no human trials specific to lavandin. Evidence level: Preliminary (preclinical only).
Insecticidal / nematicidal: Controlled laboratory and greenhouse experiments in multiple cultivars; no field or human studies relevant. Evidence level: Moderate for agricultural/in vitro context.
Antithrombotic / antiplatelet: Limited in vitro / ex vivo evidence. Evidence level: Preliminary.
Contact sensitization risk (oxidized linalool): Well-documented in multiple epidemiological and mechanistic studies across thousands of patients. Evidence level: Strong.